Raymond James & Associates Ingevity Corp Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 24, 2023
BUY
$46.86 - $64.31 $24,179 - $33,183
516 Added 1.12%
46,519 $2.21 Million
Q2 2023

Jul 25, 2023
BUY
$47.19 - $74.01 $13,213 - $20,722
280 Added 0.61%
46,003 $2.68 Million
Q1 2023

Apr 14, 2023
BUY
$68.71 - $90.75 $82,314 - $108,718
1,198 Added 2.69%
45,723 $3.27 Million
Q4 2022

Feb 08, 2023
SELL
$61.2 - $78.95 $6,303 - $8,131
-103 Reduced 0.23%
44,525 $3.14 Million
Q3 2022

Oct 25, 2022
BUY
$60.02 - $75.11 $61,580 - $77,062
1,026 Added 2.35%
44,628 $2.71 Million
Q2 2022

Aug 12, 2022
BUY
$59.46 - $74.1 $115,887 - $144,420
1,949 Added 4.68%
43,602 $2.75 Million
Q1 2022

May 11, 2022
BUY
$56.58 - $75.67 $80,626 - $107,829
1,425 Added 3.54%
41,653 $2.67 Million
Q4 2021

Feb 08, 2022
BUY
$69.65 - $83.18 $393,383 - $469,800
5,648 Added 16.33%
40,228 $2.88 Million
Q3 2021

Nov 02, 2021
SELL
$69.6 - $87.31 $54,218 - $68,014
-779 Reduced 2.2%
34,580 $2.47 Million
Q2 2021

Aug 11, 2021
BUY
$70.45 - $89.41 $42,410 - $53,824
602 Added 1.73%
35,359 $2.88 Million
Q1 2021

May 14, 2021
SELL
$65.69 - $79.62 $77,185 - $93,553
-1,175 Reduced 3.27%
34,757 $2.63 Million
Q4 2020

Feb 12, 2021
SELL
$49.95 - $75.73 $3.36 Million - $5.1 Million
-67,294 Reduced 65.19%
35,932 $2.72 Million
Q3 2020

Nov 04, 2020
SELL
$48.21 - $63.11 $135,662 - $177,591
-2,814 Reduced 2.65%
103,226 $5.1 Million
Q2 2020

Jul 28, 2020
BUY
$34.66 - $57.89 $1.22 Million - $2.04 Million
35,192 Added 49.67%
106,040 $5.58 Million
Q1 2020

Apr 21, 2020
BUY
$27.84 - $86.29 $809,253 - $2.51 Million
29,068 Added 69.57%
70,848 $2.49 Million
Q4 2019

Feb 12, 2020
SELL
$78.04 - $94.05 $61,183 - $73,735
-784 Reduced 1.84%
41,780 $3.65 Million
Q3 2019

Nov 07, 2019
BUY
$73.16 - $107.57 $731,673 - $1.08 Million
10,001 Added 30.71%
42,564 $3.61 Million
Q2 2019

Aug 06, 2019
BUY
$86.26 - $115.77 $76,512 - $102,687
887 Added 2.8%
32,563 $3.43 Million
Q1 2019

May 06, 2019
SELL
$79.69 - $117.07 $22,313 - $32,779
-280 Reduced 0.88%
31,676 $3.35 Million
Q4 2018

Feb 11, 2019
SELL
$75.51 - $103.34 $221,395 - $302,992
-2,932 Reduced 8.4%
31,956 $2.67 Million
Q3 2018

Nov 14, 2018
BUY
$80.77 - $104.93 $115,016 - $149,420
1,424 Added 4.26%
34,888 $3.55 Million
Q2 2018

Aug 14, 2018
BUY
$71.5 - $84.03 $17,303 - $20,335
242 Added 0.73%
33,464 $2.71 Million
Q1 2018

May 14, 2018
BUY
$69.14 - $81.49 $7,328 - $8,637
106 Added 0.32%
33,222 $2.45 Million
Q4 2017

Feb 14, 2018
BUY
$64.49 - $79.59 $44,046 - $54,359
683 Added 2.11%
33,116 $2.33 Million
Q3 2017

Nov 13, 2017
BUY
$55.74 - $63.91 $334 - $383
6 Added 0.02%
32,433 $2.03 Million
Q2 2017

Aug 14, 2017
BUY
N/A
32,427
32,427 $1.86 Million

Others Institutions Holding NGVT

# of Institutions
276
Shares Held
36.1M
Call Options Held
2.1K
Put Options Held
1.2K
View Full List

About Ingevity Corp

NGVT Quotes by TradingView
  • Ticker NGVT
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 38,048,800
  • Market Cap $1.75B
  • Description
  • Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells har...
More about NGVT
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email